TOP TIERMARKET NEWSWIRE
News & sentiment

ZEVRA THERAPEUTICS I (ZVRA) — News & AI sentiment

ZEVRA THERAPEUTICS I (ZVRA) news roundup. 12 stories in the past week, 13 over 30 days. Average 30-day sentiment is 38.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $459K — net selling of $459K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
12
avg sentiment 37.3/100
30d stories
13
avg sentiment 38.2/100
Insider net (90d)
$459K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on ZVRA

2d ago
BTIG cuts Zevra Therapeutics price target on EU setback
Investing.com Analyst Ratings34 · bearishanalyst
2d ago
2d ago
H.C. Wainwright reiterates Zevra stock rating on EU setback
Investing.com Analyst Ratings42 · neutralanalyst
3d ago
6d ago
6d ago
6d ago
6d ago
Zevra plunges on EU snub for rare disease therapy
Seeking Alpha28 · bearishgeneral
6d ago
6d ago
6d ago
Zevra Therapeutics: Worthy Of An Initial Holding
Seeking Alpha67 · bullishproduct/pr
7d ago
Jul 22
Jun 23
Jun 11
Jun 9
Jun 8
Jun 8
Jun 5
May 29
May 7
May 7
Zevra (ZVRA) Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
May 6
Open ZVRA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →